Interestingly, FTO may attenuate gemcitabine resistance in Pancreatic cancer by modulating neural precursor cell expressed developmentally downregulated 4 (NEDD4) mRNA stability through the PTEN/PI3K/AKT signaling axis. The gene discussed is NEDD4; the disease is familial pancreatic carcinoma.